Monday, 3-17-14, the multi-billion dollar trial against Takeda Pharmaceuticals will begin. The Japanese firm makes the drug pioglitazone, marketed under the trade name Actos. Taking place in Las Vegas, Delores Cipriano and another plaintiff claim the diabetes drug Actos caused them to develop bladder cancer. Attorney Robert Eglet, attorney for Cipriano, plans to ask for a 1 billion dollar verdict. Thousands of cases have been filed nationwide.
Eglet holds the three biggest personal injury verdicts in Nevada. Jury selection began February 10th, and was completed on Tuesday. The trial is expected to last 8-10 week, and may have repercussions for for other lawsuits across the nation. At issue is whether Takeda Pharmaceuticals failed to adequately inform medical professionals and consumers regarding the risk associated with Actos. In 2011, the FDA warned that Actos may be associated with an increased rick of bladder cancer.
Eglet is asking for punitive damages, and it is expected that Takeda Pharmaceuticals would appeal any large verdict. A multidistrict case involving hundreds of plaintiffs is taking place simultaneously in the Western District of Louisiana. (MDL No 2299), although it appears that case has much longer to go before any sort of trial would take place, if at all.